glp-1 agonist prediabetes New Guidelines for Type 2 Diabetes in 2025 DPP4 Inhibitors vs GLP-1 Agonists
Description
It covers one of the same receptor pathways but eliminates the GIP component, which may be responsible for your specific side effects
Physiol Rev (2007) 87:140939
Meanwhile, Eli Lilly is gearing up to introduce orforglipron calcium, which is expected to hit the market by 2026
Cao YY, Chen ZW, Gao YH, Wang XX, Ma JY, Chang SF, Qian JY, Ge JB
The appetite suppression and delayed gastric emptying contribute to significant weight loss, which has expanded their clinical applications beyond diabetes management
